Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nevus, Pigmented | 4 | 2022 | 222 | 1.520 |
Why?
|
| Skin Neoplasms | 11 | 2024 | 5809 | 1.280 |
Why?
|
| Melanoma | 10 | 2024 | 5694 | 1.090 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 2 | 2024 | 70 | 1.050 |
Why?
|
| Granuloma, Pyogenic | 1 | 2021 | 47 | 0.750 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2024 | 455 | 0.740 |
Why?
|
| Perfume | 1 | 2020 | 9 | 0.700 |
Why?
|
| Peroxides | 1 | 2020 | 74 | 0.670 |
Why?
|
| Sunburn | 1 | 2019 | 156 | 0.610 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2020 | 111 | 0.610 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 1743 | 0.480 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2020 | 557 | 0.480 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2024 | 2803 | 0.460 |
Why?
|
| Skin | 3 | 2021 | 4473 | 0.410 |
Why?
|
| Allergens | 1 | 2020 | 1433 | 0.400 |
Why?
|
| Nevus, Blue | 1 | 2023 | 43 | 0.220 |
Why?
|
| Child | 13 | 2024 | 80154 | 0.200 |
Why?
|
| Nevus of Ota | 1 | 2021 | 3 | 0.190 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2020 | 38 | 0.170 |
Why?
|
| Patch Tests | 1 | 2020 | 57 | 0.170 |
Why?
|
| Mutation | 1 | 2024 | 30004 | 0.170 |
Why?
|
| Melanosis | 1 | 2021 | 93 | 0.170 |
Why?
|
| Adolescent | 10 | 2024 | 88300 | 0.160 |
Why?
|
| Biopsy | 2 | 2021 | 6781 | 0.160 |
Why?
|
| Antipsychotic Agents | 3 | 2017 | 3064 | 0.160 |
Why?
|
| Drug Eruptions | 1 | 2021 | 335 | 0.150 |
Why?
|
| Sulfides | 1 | 2017 | 168 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 2517 | 0.140 |
Why?
|
| Pregnancy Complications | 2 | 2022 | 2949 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2024 | 2054 | 0.120 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 349 | 0.110 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2015 | 339 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 915 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2024 | 42225 | 0.100 |
Why?
|
| Massachusetts | 3 | 2020 | 8837 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2159 | 0.100 |
Why?
|
| Language | 1 | 2021 | 1539 | 0.100 |
Why?
|
| Dermatology | 1 | 2021 | 918 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2024 | 11067 | 0.090 |
Why?
|
| Humans | 22 | 2024 | 761222 | 0.090 |
Why?
|
| Depressive Disorder, Major | 2 | 2018 | 4767 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2756 | 0.080 |
Why?
|
| Menopause | 1 | 2017 | 1646 | 0.080 |
Why?
|
| Survivors | 1 | 2019 | 2369 | 0.080 |
Why?
|
| Vitamins | 1 | 2015 | 1634 | 0.070 |
Why?
|
| Piperazines | 1 | 2017 | 2522 | 0.070 |
Why?
|
| Registries | 3 | 2021 | 8246 | 0.070 |
Why?
|
| Parents | 1 | 2019 | 3564 | 0.060 |
Why?
|
| Female | 11 | 2024 | 392552 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3410 | 0.050 |
Why?
|
| Male | 6 | 2024 | 360703 | 0.050 |
Why?
|
| Incidence | 1 | 2020 | 21366 | 0.050 |
Why?
|
| Vitamin D | 1 | 2015 | 3301 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13511 | 0.050 |
Why?
|
| Adult | 9 | 2023 | 221120 | 0.050 |
Why?
|
| Infant | 2 | 2020 | 36170 | 0.050 |
Why?
|
| Scalp | 1 | 2023 | 389 | 0.050 |
Why?
|
| Young Adult | 4 | 2020 | 59222 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6988 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2021 | 147 | 0.040 |
Why?
|
| Aminoquinolines | 1 | 2020 | 106 | 0.040 |
Why?
|
| Pregnancy | 5 | 2022 | 29893 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2017 | 6823 | 0.040 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2023 | 732 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2021 | 414 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 80675 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 934 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2020 | 1642 | 0.030 |
Why?
|
| Pregnancy Trimesters | 1 | 2015 | 197 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2022 | 2426 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2015 | 799 | 0.020 |
Why?
|
| Boston | 1 | 2023 | 9327 | 0.020 |
Why?
|
| Pregnant Women | 1 | 2015 | 568 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2022 | 2893 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4513 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 39127 | 0.020 |
Why?
|
| Folic Acid | 1 | 2015 | 1323 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2374 | 0.020 |
Why?
|
| Health Policy | 1 | 2021 | 2679 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2015 | 1141 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 6011 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5829 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 2923 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 7046 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 220858 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12952 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22174 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 74241 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 54437 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64681 | 0.010 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_